GRI
GRI Bio, Inc.
Company overview
- Market capitalization
- $4.59M
- Employees
- 3
- Latest publication
- 2026-09-29
About GRI Bio, Inc.
GRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies that target diseases leading to inflammatory, fibrotic, and autoimmune disorders in the United States. Its lead product candidate is GRI-0621, an oral inhibitor of type 1 Natural Killer T cells, which is in phase IIa clinical trial for the treatment of severe fibrotic lung diseases, such as idiopathic pulmonary fibrosis. The company's portfolio also includes GRI-0803, a novel oral agonist of type 2 Natural Killer T cells that is in preclinical development for the treatment of autoimmune disorders; a proprietary library of 500+ compounds; and GRI-0124 and GRI-0729 for balance inflammatory immune responses. The company was formerly known as Glycoregimmune, Inc. GRI Bio, Inc. was founded in 2009 and is based in LA Jolla, California.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 6,333,000USD | 22,538,000USD | 0USD | 2,298,000USD | 0USD | 0USD |
| Cost Of Revenue | 1,000USD | 1,000USD | 3,364,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD |
| Gross Profit | -1,000USD | -1,000USD | -1,000USD | -1,000USD | -1,000USD | -1,000USD | -1,000USD | -1,000USD |
| Research Development | 361,000USD | 1,631,000USD | 1,769,000USD | 1,879,000USD | 1,640,000USD | 829,000USD | 1,130,000USD | 877,000USD |
| Selling General Administrative | 1,642,000USD | 1,033,000USD | 1,596,000USD | 1,018,000USD | 1,411,000USD | 1,063,000USD | 1,005,000USD | 1,380,000USD |
| Total Operating Expenses | 2,003,000USD | 2,664,000USD | 3,365,000USD | 2,896,000USD | 3,051,000USD | 1,953,000USD | 2,129,000USD | 2,256,000USD |
| Operating Income | -2,003,000USD | -2,664,000USD | -3,365,000USD | -2,897,000USD | -3,051,000USD | -1,954,000USD | -2,130,000USD | -2,257,000USD |
| Interest Income | 5,000USD | 5,000USD | 6,000USD | 5,000USD | 5,000USD | — | 7,000USD | 6,000USD |
| Net Interest Income | 5,000USD | 5,000USD | 6,000USD | 5,000USD | 5,000USD | 6,000USD | 7,000USD | 6,000USD |
| Income Before Tax | -1,998,000USD | -2,659,000USD | -3,359,000USD | -2,892,000USD | -3,046,000USD | -1,948,000USD | -2,123,000USD | -2,250,000USD |
| Net Income | -1,998,000USD | -2,659,000USD | -3,359,000USD | -2,892,000USD | -3,046,000USD | -1,948,000USD | -2,123,000USD | -2,250,000USD |
| Net Income From Continuing Ops | -1,998,000USD | -2,659,000USD | -3,359,000USD | -2,892,000USD | -3,046,000USD | -1,948,000USD | -2,123,000USD | -2,250,000USD |
| Ebit | -2,003,000USD | -2,664,000USD | -3,365,000USD | -2,892,000USD | -3,051,000USD | -1,948,000USD | -2,123,000USD | -2,250,000USD |
| Ebitda | -2,002,000USD | -2,663,000USD | -3,364,000USD | -2,891,000USD | -3,050,000USD | -1,947,000USD | -2,122,000USD | -2,249,000USD |
| Depreciation And Amortization | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD |
| Reconciled Depreciation | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD |
| Total Other Income Expense Net | 5,000USD | 5,000USD | 6,000USD | 5,000USD | 5,000USD | 6,000USD | 7,000USD | 7,000USD |
| Income Tax Expense | — | — | 752,000USD | — | — | 654,000USD | — | -42,276USD |
| Selling And Marketing Expenses | — | — | — | — | — | 62,000USD | — | 1,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 22,538,000USD | 21,767,000USD | 0USD | 0USD | 100,000USD | — | — |
| Cost Of Revenue | 4,000USD | 4,000USD | 57,000USD | 50,000USD | 73,000USD | 100,000USD | 735USD | 612USD |
| Gross Profit | -4,000USD | -4,000USD | -57,000USD | -50,000USD | -73,000USD | 100,000USD | -735USD | -612USD |
| Research Development | 6,819,000USD | 3,768,000USD | 3,232,000USD | 242,000USD | 5,187,000USD | 264,000USD | 1,882,434USD | 3,513,019USD |
| Selling General Administrative | 5,158,000USD | 4,405,000USD | 8,096,000USD | 1,997,000USD | 813,000USD | 1,195,000USD | — | — |
| Total Operating Expenses | 11,977,000USD | 8,231,000USD | 11,330,000USD | 2,189,000USD | 9,186,000USD | 1,459,000USD | 3,153,686USD | 4,313,095USD |
| Operating Income | -11,977,000USD | -8,234,999USD | -11,387,000USD | -2,239,000USD | -9,259,000USD | -1,459,000USD | -3,154,421USD | -4,313,707USD |
| Interest Income | 21,000USD | 25,000USD | — | — | — | — | — | — |
| Net Interest Income | 21,000USD | 25,000USD | -2,366,000USD | -653,000USD | -547,000USD | — | — | — |
| Income Before Tax | -11,956,000USD | -8,207,000USD | -13,037,000USD | -3,217,000USD | -9,303,000USD | -2,531,000USD | -3,464,492USD | -4,312,646USD |
| Net Income | -11,956,000USD | -8,207,000USD | -13,037,000USD | -3,217,000USD | -9,303,000USD | -2,531,000USD | -3,464,492USD | -4,312,646USD |
| Net Income From Continuing Ops | -11,956,000USD | -8,207,000USD | -13,302,000USD | -3,217,000USD | -1,559,000USD | — | — | — |
| Ebit | -11,977,000USD | -8,206,999USD | -10,955,000USD | -2,564,000USD | -9,287,000USD | -1,459,000USD | -3,267,466USD | -4,312,646USD |
| Ebitda | -11,973,000USD | -8,202,999USD | -10,898,000USD | -2,514,000USD | -9,214,000USD | -1,456,000USD | -3,266,731USD | -4,312,034USD |
| Depreciation And Amortization | 4,000USD | 4,000USD | 57,000USD | 50,000USD | 73,000USD | 3,000USD | 735USD | 612USD |
| Reconciled Depreciation | 4,000USD | 4,000USD | 51,000USD | 50,000USD | 49,000USD | — | — | — |
| Total Other Income Expense Net | 21,000USD | 27,999USD | -1,650,000USD | -978,000USD | -44,000USD | -1,072,000USD | -310,071USD | 1,061USD |
| Selling And Marketing Expenses | — | 62,000USD | — | — | — | — | — | — |
| Interest Expense | — | 6,000USD | 2,081,999USD | 653,000USD | 16,000USD | 34,000USD | 197,026USD | — |
| Income Tax Expense | — | — | 2,765,000USD | 325,000USD | -50,000USD | -131,297USD | 5USD | -2USD |
| Unclassified Operating Expenses | — | — | — | — | 3,186,000USD | — | 1,271,252USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 11,380,000USD | 11,339,000USD | 8,666,000USD | 4,782,000USD | 5,675,000USD | 4,042,000USD | 5,739,000USD | 5,459,000USD |
| Cash And Equivalents | 10,947,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 11,334,000USD | 11,279,000USD | 8,592,000USD | 4,697,000USD | 5,576,000USD | 3,930,000USD | 5,615,000USD | 5,323,000USD |
| Other Current Assets | 387,000USD | 231,000USD | 363,000USD | 642,000USD | 454,000USD | 649,000USD | 587,000USD | 577,000USD |
| Total Liabilities | 1,100,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 1,100,000USD | 794,000USD | 2,643,000USD | 2,759,000USD | 2,309,000USD | 2,779,000USD | 1,636,000USD | 1,715,000USD |
| Other Current Liabilities | 530,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 10,280,000USD | 10,545,000USD | 6,008,000USD | 1,993,000USD | 3,322,000USD | 1,205,000USD | 4,032,000USD | 3,660,000USD |
| Total Equity Including Noncontrolling Interest | 10,280,000USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 46,000USD | 60,000USD | 74,000USD | 85,000USD | 99,000USD | 112,000USD | 124,000USD | 136,000USD |
| Accounts Payable | 526,000USD | 303,000USD | 1,837,000USD | 1,317,000USD | 1,297,000USD | 1,361,000USD | 897,000USD | 1,137,000USD |
| Short Term Debt | 44,000USD | 58,000USD | 56,000USD | 54,000USD | 52,000USD | 50,000USD | 48,000USD | 47,000USD |
| Retained Earnings | -55,337,000USD | -53,694,000USD | -51,696,000USD | -49,037,000USD | -45,678,000USD | -42,786,000USD | -39,740,000USD | -37,793,000USD |
| Total Liab | — | 794,000USD | 2,658,000USD | 2,789,000USD | 2,353,000USD | 2,837,000USD | 1,707,000USD | 1,799,000USD |
| Other Current Liab | — | 433,000USD | 750,000USD | 1,104,000USD | 960,000USD | 1,368,000USD | 691,000USD | 531,000USD |
| Capital Stock | — | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Cash | — | 11,048,000USD | 8,229,000USD | 4,055,000USD | 5,122,000USD | 3,281,000USD | 5,028,000USD | 4,746,000USD |
| Cash And Short Term Investments | — | 11,048,000USD | 8,229,000USD | 4,055,000USD | 5,122,000USD | 3,281,000USD | 5,028,000USD | 4,746,000USD |
| Net Debt | — | -10,990,000USD | -8,158,000USD | -3,971,000USD | -5,026,000USD | -3,173,000USD | -4,909,000USD | -4,615,000USD |
| Short Long Term Debt Total | — | 58,000USD | 71,000USD | 84,000USD | 96,000USD | 108,000USD | 119,000USD | 131,000USD |
| Property Plant Equipment Gross | — | 95,000USD | 108,000USD | 118,000USD | 131,000USD | 143,000USD | 154,000USD | 165,000USD |
| Common Stock Shares Outstanding | — | 1,241,000shares | 497,696shares | 93,625shares | 78,755shares | 525,447shares | 6,546shares | 6,640shares |
| Non Current Assets Total | — | 60,000USD | 74,000USD | 85,000USD | 99,000USD | 112,000USD | 124,000USD | 136,000USD |
| Non Current Liabilities Total | — | 0USD | 15,000USD | 30,000USD | 44,000USD | 58,000USD | 71,000USD | 84,000USD |
| Net Working Capital | — | 10,485,000USD | 5,949,000USD | 1,938,000USD | 3,267,000USD | 1,151,000USD | 3,979,000USD | 3,608,000USD |
| Unclassified Equity | — | 64,239,000USD | 57,704,000USD | 50,099,000USD | 48,226,000USD | 43,991,000USD | 42,964,000USD | 41,453,000USD |
| Common Stock | — | — | — | 850,000USD | 850,000USD | — | 850,000USD | — |
| Current Deferred Revenue | — | — | — | 15,000USD | — | — | 13,000USD | — |
| Accumulated Other Comprehensive Income | — | — | — | 81,000USD | -76,000USD | — | -42,000USD | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 8,666,000USD | 5,739,000USD | 2,956,000USD | 383,000USD | 218,000USD | 955,000USD | 4,275,656USD | 639,231USD |
| Other Current Assets | 363,000USD | 587,000USD | 1,126,000USD | 303,000USD | 6,000USD | 565,000USD | 100,860USD | 24,987USD |
| Total Liab | 2,658,000USD | 1,707,000USD | 2,697,000USD | 2,008,000USD | 4,942,000USD | 2,409,000USD | 1,061,854USD | 486,292USD |
| Total Stockholder Equity | 6,008,000USD | 4,032,000USD | 259,000USD | -1,625,000USD | -4,724,000USD | -1,454,000USD | 3,213,802USD | 152,939USD |
| Other Current Liab | 750,000USD | 691,000USD | 1,273,000USD | 41,000USD | 1,271,000USD | 766,000USD | 475,504USD | 199,679USD |
| Capital Stock | 0USD | 0USD | 0USD | 267,000USD | 352,000USD | — | — | — |
| Retained Earnings | -51,696,000USD | -39,740,000USD | -31,533,000USD | -18,496,000USD | -15,279,000USD | -12,599,000USD | -7,777,138USD | -4,312,646USD |
| Cash | 8,229,000USD | 5,028,000USD | 1,808,000USD | 9,000USD | 90,000USD | 109,000USD | 3,820,894USD | 612,652USD |
| Cash And Short Term Investments | 8,229,000USD | 5,028,000USD | 1,808,000USD | 9,000USD | 90,000USD | 109,000USD | 3,820,894USD | 612,652USD |
| Total Current Assets | 8,592,000USD | 5,615,000USD | 2,934,000USD | 312,000USD | 96,000USD | 674,000USD | 3,921,754USD | 637,639USD |
| Total Current Liabilities | 2,643,000USD | 1,636,000USD | 2,697,000USD | 1,994,000USD | 4,875,000USD | 2,225,000USD | 807,498USD | 486,292USD |
| Net Debt | -8,158,000USD | -4,909,000USD | -1,794,000USD | 664,000USD | 3,524,000USD | 227,000USD | -3,480,873USD | -612,652USD |
| Short Term Debt | 56,000USD | 48,000USD | 14,000USD | 659,000USD | 3,547,000USD | 152,000USD | 85,665USD | — |
| Short Long Term Debt Total | 71,000USD | 119,000USD | 14,000USD | 673,000USD | 3,614,000USD | 336,000USD | 340,021USD | — |
| Accounts Payable | 1,837,000USD | 897,000USD | 1,410,000USD | 1,294,000USD | 57,000USD | 1,226,000USD | 246,329USD | 286,613USD |
| Property Plant Equipment Net | 74,000USD | 124,000USD | 22,000USD | 71,000USD | 117,000USD | 281,000USD | 353,902USD | 1,592USD |
| Property Plant Equipment Gross | 108,000USD | 154,000USD | 48,000USD | 93,000USD | 137,000USD | — | — | — |
| Common Stock Shares Outstanding | 98,162shares | 6,546shares | 1,578shares | 1,160shares | 11,602shares | 891shares | 891shares | 891shares |
| Non Current Assets Total | 74,000USD | 124,000USD | 22,000USD | 71,000USD | 122,000USD | 281,000USD | 353,901USD | 1,592USD |
| Non Current Liabilities Total | 15,000USD | 71,000USD | 0USD | 14,000USD | 67,000USD | 184,000USD | 254,356USD | — |
| Net Working Capital | 5,949,000USD | 3,979,000USD | 237,000USD | -1,686,000USD | -4,779,000USD | — | — | — |
| Unclassified Equity | 57,704,000USD | 43,772,000USD | 31,792,000USD | 16,603,000USD | 9,853,000USD | 10,918,000USD | 10,972,915USD | 4,454,335USD |
| Other Assets | — | — | 1USD | — | — | 1USD | 1USD | — |
| Non Currrent Assets Other | — | — | -1USD | 4,000USD | 5,000USD | -1USD | -1USD | 0USD |
| Common Stock | — | — | — | 1,000USD | 352,000USD | 227,000USD | 18,025USD | 11,250USD |
| Current Deferred Revenue | — | — | — | 5,000USD | 62,000USD | 81,000USD | — | — |
| Short Long Term Debt | — | — | — | 602,000USD | 3,500,000USD | — | — | — |
| Short Term Investments | — | — | — | — | 3,808,000USD | — | — | — |
| Accumulated Other Comprehensive Income | — | — | — | — | -2,000USD | — | — | — |
| Unclassified Current Assets | — | — | — | — | -3,808,000USD | — | — | — |
| Unclassified Current Liabilities | — | — | — | — | -3,562,000USD | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 1,000USD |
| Stock Based Compensation | 64,000USD |
| Change To Liabilities | -1,504,000USD |
| Change In Working Capital | -1,335,000USD |
| Operating Cash Flow | -5,131,000USD |
| Financing Cash Flow | 7,849,000USD |
| Change In Cash | 2,718,000USD |
| End Cash Flow | 10,947,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -1,998,000USD | -2,659,000USD | -3,359,000USD | -2,892,000USD | -3,046,000USD | -1,948,000USD | -2,122,000USD | -2,250,000USD |
| Depreciation | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD |
| Stock Based Compensation | 31,000USD | 67,000USD | 465,000USD | 41,000USD | 220,000USD | 37,000USD | 37,000USD | 37,000USD |
| Other Non Cash Items | 44,000USD | 12,000USD | 13,000USD | 12,000USD | 11,000USD | 12,000USD | 10,000USD | -142,000USD |
| Change In Working Capital | -1,732,000USD | -392,000USD | 567,000USD | -328,000USD | 1,078,000USD | -101,000USD | -194,000USD | 213,000USD |
| Total Cash From Operating Activities | -3,685,000USD | -2,971,000USD | -2,313,000USD | -3,166,000USD | -1,736,000USD | -1,999,000USD | -2,268,000USD | -2,141,000USD |
| Capital Expenditures | 0USD | -3,000USD | 0USD | -396,000USD | 0USD | 0USD | 0USD | 0USD |
| Free Cash Flow | -3,685,000USD | -2,974,000USD | -2,313,000USD | -3,166,000USD | -1,736,000USD | -1,999,000USD | -2,268,000USD | -2,141,000USD |
| Total Cash From Financing Activities | 6,504,000USD | 7,148,000USD | 1,246,000USD | 5,007,000USD | -11,000USD | 2,281,000USD | 661,000USD | 4,403,000USD |
| Sale Purchase Of Stock | -1,000USD | 0USD | 0USD | -1,000USD | -1,000USD | 0USD | -1,000USD | 0USD |
| Issuance Of Capital Stock | 6,819,000USD | 8,000,000USD | 1,619,000USD | 5,941,000USD | 0USD | 1,616,000USD | 1,027,000USD | 4,960,000USD |
| Change In Cash | 2,819,000USD | 4,174,000USD | -1,067,000USD | 1,841,000USD | -1,747,000USD | 282,000USD | -1,607,000USD | 2,262,000USD |
| Begin Period Cash Flow | 8,228,999USD | 4,055,000USD | 5,122,000USD | 3,281,000USD | 5,028,000USD | 4,746,000USD | 6,353,000USD | 4,091,000USD |
| End Period Cash Flow | 11,048,000USD | 8,229,000USD | 4,055,000USD | 5,122,000USD | 3,281,000USD | 5,028,000USD | 4,746,000USD | 6,353,000USD |
| Other Cashflows From Financing Activities | -1,000USD | -852,000USD | -373,000USD | -934,000USD | -10,000USD | 665,000USD | -365,000USD | -557,000USD |
| Unclassified Financing Cash Flow | 6,506,000USD | 8,000,000USD | 1,619,000USD | 5,942,000USD | — | 1,616,000USD | 1,027,000USD | 4,960,000USD |
| Total Cashflows From Investing Activities | — | -3,000USD | — | -429,000USD | — | — | — | — |
| Other Cashflows From Investing Activities | — | — | — | 396,000USD | — | — | — | — |
| Investments | — | — | — | — | — | 0USD | 0USD | — |
| Net Borrowings | — | — | — | — | — | 0USD | 0USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -11,956,000USD | -8,207,000USD | -13,037,000USD | -3,217,000USD | -1,559,000USD | -4,822,000USD | -3,464,492USD | -4,312,646USD |
| Depreciation | 4,000USD | 4,000USD | 4,000USD | 3,000USD | 49,000USD | 75,000USD | 735USD | 612USD |
| Stock Based Compensation | 793,000USD | 148,000USD | 388,000USD | 25,000USD | 0USD | — | — | — |
| Other Non Cash Items | 48,000USD | -108,000USD | 1,975,000USD | 589,000USD | 100,000USD | 154,000USD | 420,354USD | 1,479,725USD |
| Change In Working Capital | 925,000USD | -448,000USD | 1,680,000USD | 1,515,000USD | 563,000USD | 887,000USD | 159,668USD | 461,305USD |
| Total Cash From Operating Activities | -10,186,000USD | -8,611,000USD | -8,990,000USD | -1,085,000USD | -847,000USD | -3,706,000USD | -2,883,735USD | -2,371,004USD |
| Capital Expenditures | -3,000USD | 0USD | -8,000USD | -3,000USD | 0USD | -2,000USD | -5USD | -2,206USD |
| Free Cash Flow | -10,189,000USD | -8,611,000USD | -8,998,000USD | -1,088,000USD | -847,000USD | -3,708,000USD | -2,883,740USD | -2,373,210USD |
| Total Cashflows From Investing Activities | -3,000USD | — | -8,000USD | -3,000USD | -3,842,000USD | -2,000USD | — | -2,204USD |
| Total Cash From Financing Activities | 13,390,000USD | 11,831,000USD | 10,797,000USD | 1,007,000USD | 600,000USD | -4,000USD | 6,091,977USD | 2,985,860USD |
| Sale Purchase Of Stock | -1,000USD | -1,000USD | 0USD | -124,000USD | 0USD | — | — | — |
| Issuance Of Capital Stock | 15,560,000USD | 13,103,000USD | 1,250,000USD | 12,250,000USD | 100,000USD | — | — | — |
| Change In Cash | 3,201,000USD | 3,220,000USD | 1,799,000USD | -81,000USD | -247,000USD | -3,711,894USD | 3,208,242USD | 612,652USD |
| Begin Period Cash Flow | 5,028,000USD | 1,808,000USD | 9,000USD | 90,000USD | 337,000USD | 3,820,894USD | 612,652USD | — |
| End Period Cash Flow | 8,229,000USD | 5,028,000USD | 1,808,000USD | 9,000USD | 90,000USD | 109,000USD | 3,820,894USD | 612,652USD |
| Other Cashflows From Financing Activities | -2,169,000USD | -1,271,000USD | -2,703,000USD | -119,000USD | -3,842,000USD | -4,000USD | -4USD | — |
| Unclassified Financing Cash Flow | 15,560,000USD | 13,103,000USD | 15,165,000USD | 3,447,000USD | 3,942,000USD | — | 6,091,981USD | — |
| Investments | — | 0USD | -11,000USD | -3,000USD | 0USD | — | — | — |
| Net Borrowings | — | 0USD | 1,250,000USD | 1,250,000USD | 500,000USD | — | — | — |
| Other Cashflows From Investing Activities | — | 396,000USD | 342,000USD | -3,782,000USD | 3,842,000USD | — | — | — |
| Change To Account Receivables | — | — | -417,000USD | — | — | — | — | — |
| Change To Inventory | — | — | -21,000USD | — | — | — | — | — |
| Dividends Paid | — | — | -2,915,000USD | -3,447,000USD | — | — | — | — |
| Unclassified Investing Cash Flow | — | — | — | 3,785,000USD | -7,684,000USD | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.